Have questions about RSV or ABRYSVO^®?

What is RSV and how can ABRYSVO help protect against it?

RSV is a highly contagious virus that can lead to serious respiratory infections and hospitalizations in at-risk adults. ABRYSVO is a single-dose vaccine that helps protect you against RSV.

Learn more about protection with ABRYSVO >

How contagious is RSV and how does it spread?

Very! RSV is a highly contagious virus. It spreads easily and rapidly through:

• A cough or sneeze
• Interactions such as a kiss or hug with someone infected with RSV
• Touching a surface with the virus—like a doorknob—then touching your face before washing your hands

Who is most at risk for RSV?

While anyone can get RSV, adults 75 years and older or 50 years and older with certain chronic medical conditions or risk factors are at higher risk for severe RSV and complications.

Learn more and see if you’re at risk >

How serious is RSV for adults 50 and older, and can it be treated?

As you age, your immune system weakens, leaving adults 50 years and older—especially those with a chronic medical condition—vulnerable to a serious case of RSV. And there are no prescription RSV treatments for adults, making vaccination especially important. For people at highest risk, the consequences of RSV include:

• Serious illness
• Severe lung infections, pneumonia and other serious respiratory complications
• Hospitalizations

Learn more about the consequences of RSV >

If I haven’t previously received an RSV vaccine, when is the best time to get protected?

In most regions of the United States, RSV season starts in the fall and peaks in the winter. Eligible adults can get an RSV vaccine at any time, but the CDC recommends that the best time to get vaccinated is in late summer and early fall, before RSV starts to spread.

How was ABRYSVO studied?

Nearly 37,000 adults aged 60 and older participated in a clinical trial, where 18,574 received ABRYSVO and 18,288 received placebo, to study the efficacy and safety of ABRYSVO.

The study tested how well a single vaccine dose of ABRYSVO could protect people against RSV-related respiratory infections.

ABRYSVO was also studied in 700 adults aged 18-59 at increased risk of RSV: 453 received ABRYSVO and 225 received placebo to assess the vaccine's effectiveness and safety.

How effective is ABRYSVO?

In a clinical study among adults 60+, ABRYSVO reduced the risk of lung infections caused by RSV.

• 86% effective in preventing RSV with 3 or more symptoms*
• 67% effective in preventing RSV with 2 or more symptoms*

Learn more about ABRYSVO including safety and side effect info >

*RSV symptoms: coughing, wheezing, mucus, shortness of breath and fast breathing.

Who is ABRYSVO for?

If you’re 75 and older or 50 and older with certain chronic medical conditions or risk factors, you’re at higher risk for a severe RSV infection and should speak with your doctor about how ABRYSVO could help protect you.

The RSV vaccine is not currently an annual vaccine, meaning people do not need to get a dose every RSV season.

Learn more and see if you’re at risk >

How will I feel after getting my ABRYSVO shot?

In a clinical study, 88% of adults aged 60+ reported no local reactions after getting ABRYSVO. The most common side effects that people did experience were tiredness, headache, injection-site pain, and muscle pain. These are not all of the possible side effects. For a full list, please see the full Prescribing Information.

Learn more about the ABRYSVO study >

Does Medicare Part D cover ABRYSVO?

Certain vaccines may be covered or available at lower out-of-pocket costs in Medicare Part D.*

How much will I have to pay for ABRYSVO? Is it covered by my insurance?

Pfizer’s ABRYSVO may be made available at no cost in accordance with the Inflation Reduction Act.*

Talk to your doctor or pharmacist to see if Pfizer’s ABRYSVO is covered under your insurance plan. Additional savings and support options may be available at Pfizer RxPathways^®.

Ask your pharmacist or doctor if ABRYSVO is covered under your insurance plan.

*This information is provided for informational purposes only. Accurate completion of reimbursement or coverage-related documentation is the responsibility of the healthcare provider and patient. Pfizer and its agents make no guarantee regarding reimbursement for any service or item.